PXD052256 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | 1,4-napthoquinone-sulfomethylene-glucose conjugates, a novel targeted approach for advanced prostate cancer |
Description | Rationale: The Warburg effect is a shift from oxidative phosphorylation to aerobic glycolysis accompanied by an enormous increase in glucose uptake into the cancer cell. We have utilized this effect to design a new group of targeted cytotoxic 1,4-naphthoquinones. To optimize the compounds for clinical use, a group of 1,4-naphthoquinone-glucose derivatives conjugated with a novel thiomethylene linker was synthesized and comprehensively evaluated. Methods: Screening experiments for efficacy and selectivity were performed in a newly synthesized library of 32 conjugates. For the most promising compound PeS-9 activity and mode of action were determined in in vitro, ex vivo and in vivo experiments using different models for prostate cancer (PCa) including human cell lines with various resistance profiles as well as patients-derived tumoroids. Additional experiments were carried out to determine the stability of PeS-9 in the blood as well as possible side effects. Results: The screening experiments identified PeS-9 to have a high efficacy in combination with a promising selectivity towards PCa cells. Further testing of hit compound PeS-9 revealed a selective cytotoxic activity conditioned by a GLUT-1-mediated uptake. PeS-9 induced androgen receptor degradation followed by downregulation of its signaling. In addition, increased reactive oxygen species production and enhanced DNA double-strand breaks were observed. Combinational therapy with PARP-inhibitor olaparib resulted in synergistic effects in homologous recombination deficient cells. The underlying mode of PeS-9 cytotoxic action involved mitochondria targeting, leading to a loss of mitochondrial membrane potential, release of cytochrome C and AIF, activation of caspases-3 and -9, PARP cleavage and apoptotic cell death. This process was stipulated by down-regulation of several antiapoptotic factors and induction of endoplasmic reticulum stress. Moreover, drug-induced activation of signaling pathway mediated by kinases p38, JNK1/2, and ERK1/2 was identified as important factor of the cytotoxic activity. The anticancer activity of PeS-9 could be confirmed ex vivo using patients-derived tumoroids as well as in vivo resulting in decreased tumor growth and dissemination of PCa cells to the lungs. No serious side effects were observed in animal models. In human blood, PeS-9 was more stable than the mother compound. Conclusion: In conclusion, we were able to synthesize and characterize PeS-9, a new 1,4-naphthoquinones-glucose derivative conjugated via a thiomethylene linker. This novel targeted approach exhibited potent antitumor activity and selectivity in human PCa cells mediated by the Warburg effect. The simultaneous inhibition of the AR signaling pathway in combination with increased production of reactive oxygen species make it an attractive substance both as a monotherapy and as a combination partner, especially with PARP inhibitors. |
HostingRepository | PRIDE |
AnnounceDate | 2025-04-14 |
AnnouncementXML | Submission_2025-04-14_05:09:49.015.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Thomas Mair |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | acetylated residue; monohydroxylated residue; deamidated residue; iodoacetamide derivatized residue |
Instrument | Orbitrap Fusion |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2024-05-14 04:58:24 | ID requested | |
⏵ 1 | 2025-04-14 05:09:49 | announced | |
Publication List
Dataset with its publication pending |
Keyword List
submitter keyword: 1, castration-resistant prostate cancer, combinational therapy.,4-naphthoquinone, ROS, mitochondria, Warburg effect, apoptosis |
Contact List
Sergey Dyshlovoy |
contact affiliation | Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald-Tumorzentrum, University Medical Center Hamburg-Eppendorf, Hamburg, Germany |
contact email | s.dyshlovoy@uke.de |
lab head | |
Thomas Mair |
contact affiliation | Section for Mass Spectrometry and Proteomics, University Medical Center Hamburg-Eppendorf |
contact email | t.mair@uke.de |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/04/PXD052256 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD052256
- Label: PRIDE project
- Name: 1,4-napthoquinone-sulfomethylene-glucose conjugates, a novel targeted approach for advanced prostate cancer